| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PHRS.2003.12.006 |
| P698 | PubMed publication ID | 14998556 |
| P50 | author | Silvana Gaetani | Q73283890 |
| P2093 | author name string | Daniele Piomelli | |
| Fariba Oveisi | |||
| Kevin Tai-Pang Eng | |||
| P433 | issue | 5 | |
| P304 | page(s) | 461-466 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Pharmacological Research | Q15724622 |
| P1476 | title | Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration | |
| P478 | volume | 49 |
| Q26999343 | A fatty gut feeling |
| Q37243917 | Biological functions and metabolism of oleoylethanolamide |
| Q38545827 | Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals? |
| Q37791290 | Deficits in gastrointestinal responses controlling food intake and body weight |
| Q48924623 | Dietary fatty acid composition affects food intake and gut-brain satiety signaling in Senegalese sole (Solea senegalensis, Kaup 1858) larvae and post-larvae |
| Q44879185 | Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome |
| Q38959757 | Eating disorders: from bench to bedside and back |
| Q38262627 | Fat sensing and metabolic syndrome |
| Q37194726 | Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. |
| Q35893930 | Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents |
| Q42146257 | GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell |
| Q38208787 | Gut microbiota and GLP-1. |
| Q92917437 | Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa |
| Q33944259 | Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity |
| Q42655791 | Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity |
| Q37352232 | Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals |
| Q87859320 | Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine |
| Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
| Q44283634 | Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans |
| Q50074099 | Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour. |
| Q37717854 | Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite |
| Q36358693 | Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells |
| Q33688649 | Satiety and eating patterns in two species of constricting snakes |
| Q42909539 | Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry |
| Q34130023 | Solubility and bioavailability of stabilized amorphous calcium carbonate. |
| Q28581609 | Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats |
| Q37126252 | The Macronutrients, Appetite, and Energy Intake. |
| Q36948170 | The lipid messenger OEA links dietary fat intake to satiety. |
| Q36772888 | Thermogenic and metabolic antiobesity drugs: rationale and opportunities |
Search more.